{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T03:51:41Z","timestamp":1767153101939,"version":"build-2238731810"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,3,22]],"date-time":"2019-03-22T00:00:00Z","timestamp":1553212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,3,22]],"date-time":"2019-03-22T00:00:00Z","timestamp":1553212800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["3\/1\/3\/PDF-2010\/HRD-11\/2ndbatch"],"award-info":[{"award-number":["3\/1\/3\/PDF-2010\/HRD-11\/2ndbatch"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["3\/1\/3\/PDF-2010\/HRD-11\/2ndbatch"],"award-info":[{"award-number":["3\/1\/3\/PDF-2010\/HRD-11\/2ndbatch"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["3\/1\/3\/PDF-2010\/HRD-11\/2ndbatch"],"award-info":[{"award-number":["3\/1\/3\/PDF-2010\/HRD-11\/2ndbatch"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["3\/1\/3\/PDF-2010\/HRD-11\/2ndbatch"],"award-info":[{"award-number":["3\/1\/3\/PDF-2010\/HRD-11\/2ndbatch"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["Post-doc fellowship Grant no. 3\/1\/3\/PDF-2010\/HRD-11\/2nd batch"],"award-info":[{"award-number":["Post-doc fellowship Grant no. 3\/1\/3\/PDF-2010\/HRD-11\/2nd batch"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Adenocarcinoma (ADC) of the uterine cervix (UC) is a rare form of cervical cancer (CC) caused due to the infection of Human Papilloma Virus (HPV). Cyclin D1 is one of the downstream targets of aberrantly activated Notch signaling, contribute to the etiology of CC. However, little is known about the role of Cyclin D1 in the modulation of cervical ADC and is controversial. The purpose of this study is to determine the role of Cyclin D1 protein and to elucidate the combined analysis with Notch signaling proteins in HPV associated ADCs of CC. A total of 60 biopsy samples (40 normal and 20 ADCs of CC) were analyzed for the expression of Cyclin D1 in HPV associated ADCs via immunohistochemistry and by immunoblotting. HPV-16 positive ADC patients showed a strong association with the Cyclin D1 expression (p\u2009=\u20090.007). The significant mean difference (p\u2009=\u20090.0001) and the pairwise comparison between Cyclin D1\/JAG1 (p\u2009=\u20090.0001), and Cyclin D1\/Notch-3 (p\u2009=\u20090.0001) were observed. The above Notch signaling proteins showed their synergistic role in modulating Cyclin D1 which in-turn regulates HPV-16 associated ADC of the uterine cervix (UC), affecting women\u2019s global health.<\/jats:p>","DOI":"10.1038\/s41598-019-41394-9","type":"journal-article","created":{"date-parts":[[2019,3,22]],"date-time":"2019-03-22T07:03:26Z","timestamp":1553238206000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Cyclin D1 protein affecting global women\u2019s health by regulating HPV mediated adenocarcinoma of the uterine cervix"],"prefix":"10.1038","volume":"9","author":[{"given":"Richa","family":"Tripathi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gayatri","family":"Rath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Poonam","family":"Jawanjal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mausumi","family":"Bharadwaj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ravi","family":"Mehrotra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,3,22]]},"reference":[{"key":"41394_CR1","doi-asserted-by":"crossref","first-page":"E359","DOI":"10.1002\/ijc.29210","volume":"136","author":"J Ferlay","year":"2015","unstructured":"Ferlay, J. et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136, E359\u2013386 (2015).","journal-title":"Int J Cancer"},{"key":"41394_CR2","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s12038-009-0013-7","volume":"34","author":"N Ganguly","year":"2009","unstructured":"Ganguly, N. & Parihar, S. P. Human papillomavirus E6 and E7 oncoproteins as risk factors for tumorigenesis. J Biosci 34, 113\u2013123 (2009).","journal-title":"J Biosci"},{"issue":"Suppl 5","key":"41394_CR3","doi-asserted-by":"publisher","first-page":"F55","DOI":"10.1016\/j.vaccine.2012.06.083","volume":"30","author":"J Doorbar","year":"2012","unstructured":"Doorbar, J. et al. The biology and life-cycle of human papillomaviruses. Vaccine 30(Suppl 5), F55\u201370 (2012).","journal-title":"Vaccine"},{"key":"41394_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2867-13-61","volume":"13","author":"TA Halim","year":"2013","unstructured":"Halim, T. A., Farooqi, A. A. & Zaman, F. Nip the HPV encoded evil in the cancer bud: HPV reshapes TRAILs and signaling landscapes. Cancer Cell Int 13, 61 (2013).","journal-title":"Cancer Cell Int"},{"key":"41394_CR5","doi-asserted-by":"publisher","first-page":"2669","DOI":"10.1016\/j.vaccine.2008.03.056","volume":"26","author":"BC Das","year":"2008","unstructured":"Das, B. C., Hussain, S., Nasare, V. & Bharadwaj, M. Prospects and prejudices of human papillomavirus vaccines in India. Vaccine 26, 2669\u20132679 (2008).","journal-title":"Vaccine"},{"key":"41394_CR6","doi-asserted-by":"publisher","first-page":"254","DOI":"10.21147\/j.issn.1000-9604.2016.02.11","volume":"28","author":"S Takeuchi","year":"2016","unstructured":"Takeuchi, S. Biology and treatment of cervical adenocarcinoma. Chin J Cancer Res 28, 254\u2013262 (2016).","journal-title":"Chin J Cancer Res"},{"key":"41394_CR7","doi-asserted-by":"publisher","first-page":"5","DOI":"10.21037\/sci.2018.02.02","volume":"5","author":"V Venkatesh","year":"2018","unstructured":"Venkatesh, V. et al. Targeting Notch signalling pathway of cancer stem cells. Stem Cell Investig 5, 5 (2018).","journal-title":"Stem Cell Investig"},{"key":"41394_CR8","doi-asserted-by":"publisher","first-page":"17766","DOI":"10.1074\/jbc.M109.003111","volume":"284","author":"K Choi","year":"2009","unstructured":"Choi, K. et al. Distinct biological roles for the notch ligands Jagged-1 and Jagged-2. J Biol Chem 284, 17766\u201317774 (2009).","journal-title":"J Biol Chem"},{"key":"41394_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-27699-1","volume":"8","author":"R Tripathi","year":"2018","unstructured":"Tripathi, R. et al. Jagged-1 induced molecular alterations in HPV associated invasive squamous cell and adenocarcinoma of the human uterine cervix. Sci Rep 8, 9359 (2018).","journal-title":"Sci Rep"},{"key":"41394_CR10","doi-asserted-by":"publisher","first-page":"e98642","DOI":"10.1371\/journal.pone.0098642","volume":"9","author":"R Tripathi","year":"2014","unstructured":"Tripathi, R. et al. Clinical impact of de-regulated Notch-1 and Notch-3 in the development and progression of HPV-associated different histological subtypes of precancerous and cancerous lesions of human uterine cervix. PLoS One 9, e98642 (2014).","journal-title":"PLoS One"},{"key":"41394_CR11","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.ygyno.2006.08.054","volume":"104","author":"B Ramdass","year":"2007","unstructured":"Ramdass, B. et al. Coexpression of Notch1 and NF-kappaB signaling pathway components in human cervical cancer progression. Gynecol Oncol 104, 352\u2013361 (2007).","journal-title":"Gynecol Oncol"},{"key":"41394_CR12","doi-asserted-by":"crossref","unstructured":"Tripathi, R. et al. HES1 Protein Modulates Human Papillomavirus-Mediated Carcinoma of the Uterine Cervix. J Glob Oncol, 1\u201310 (2019).","DOI":"10.1200\/JGO.18.00141"},{"key":"41394_CR13","doi-asserted-by":"crossref","first-page":"64526","DOI":"10.18632\/oncotarget.12267","volume":"7","author":"F Marampon","year":"2016","unstructured":"Marampon, F. et al. Cyclin D1 silencing suppresses tumorigenicity, impairs DNA double strand break repair and thus radiosensitizes androgen-independent prostate cancer cells to DNA damage. Oncotarget 7, 64526 (2016).","journal-title":"Oncotarget"},{"key":"41394_CR14","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1097\/00004347-199710000-00008","volume":"16","author":"NH Cho","year":"1997","unstructured":"Cho, N. H., Kim, Y. T. & Kim, J. W. Correlation between G1 cyclins and HPV in the uterine cervix. Int J Gynecol Pathol 16, 339\u2013347 (1997).","journal-title":"Int J Gynecol Pathol"},{"key":"41394_CR15","first-page":"1430","volume":"19","author":"R Balan","year":"2013","unstructured":"Balan, R., Caruntu, I. D. & Amalinei, C. The immunohistochemical assessment of HPV related adenocarcinoma: pathologic and clinical prognostic significance. Curr Pharm Des 19, 1430\u20131438 (2013).","journal-title":"Curr Pharm Des"},{"key":"41394_CR16","first-page":"1","volume":"1","author":"A Neyaz","year":"2017","unstructured":"Neyaz, A. et al. Synchronous Cervical Minimal Deviation Adenocarcinoma, Gastric Type Adenocarcinoma and Lobular Endocervical Glandular Hyperplasia Along with STIL in Peutz-Jeghers Syndrome: Eliciting Oncogenesis. Pathways. Turk Patoloji Derg 1, 1\u20137 (2017).","journal-title":"Pathways. Turk Patoloji Derg"},{"key":"41394_CR17","doi-asserted-by":"publisher","first-page":"470","DOI":"10.5468\/ogs.2016.59.6.470","volume":"59","author":"H Park","year":"2016","unstructured":"Park, H., Lee, M., Kim, D. W., Hong, S. Y. & Lee, H. Glycogen synthase kinase 3beta and cyclin D1 expression in cervical carcinogenesis. Obstet Gynecol Sci 59, 470\u2013478 (2016).","journal-title":"Obstet Gynecol Sci"},{"key":"41394_CR18","doi-asserted-by":"publisher","first-page":"2929","DOI":"10.3892\/ol.2017.5848","volume":"13","author":"R Tong","year":"2017","unstructured":"Tong, R., Yang, Q., Wang, C., Bi, F. & Jiang, B. OVCA1 expression and its correlation with the expression levels of cyclin D1 and p16 in cervical cancer and intraepithelial neoplasia. Oncol Lett 13, 2929\u20132936 (2017).","journal-title":"Oncol Lett"},{"key":"41394_CR19","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/modpathol.2009.178","volume":"23","author":"L Little","year":"2010","unstructured":"Little, L. & Stewart, C. J. Cyclin D1 immunoreactivity in normal endocervix and diagnostic value in reactive and neoplastic endocervical lesions. Mod Pathol 23, 611\u2013618 (2010).","journal-title":"Mod Pathol"},{"key":"41394_CR20","doi-asserted-by":"publisher","first-page":"5110","DOI":"10.1038\/onc.2008.224","volume":"27","author":"TT Maliekal","year":"2008","unstructured":"Maliekal, T. T., Bajaj, J., Giri, V., Subramanyam, D. & Krishna, S. The role of Notch signaling in human cervical cancer: implications for solid tumors. Oncogene 27, 5110\u20135114 (2008).","journal-title":"Oncogene"},{"key":"41394_CR21","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/sj.emboj.7600902","volume":"25","author":"HM Shin","year":"2006","unstructured":"Shin, H. M. et al. Notch1 augments NF-kappaB activity by facilitating its nuclear retention. EMBO J 25, 129\u2013138 (2006).","journal-title":"EMBO J"},{"key":"41394_CR22","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4103\/0377-4929.200045","volume":"60","author":"NH Myong","year":"2017","unstructured":"Myong, N. H. Altered expressions of Notch-1 signaling proteins and beta-catenin in progression of carcinoma in situ into squamous carcinoma of uterine cervix. Indian J Pathol Microbiol 60, 21\u201326 (2017).","journal-title":"Indian J Pathol Microbiol"},{"key":"41394_CR23","doi-asserted-by":"publisher","first-page":"5925","DOI":"10.1128\/MCB.21.17.5925-5934.2001","volume":"21","author":"C Ronchini","year":"2001","unstructured":"Ronchini, C. & Capobianco, A. J. Induction of cyclin D1 transcription and CDK2 activity by Notch(ic): implication for cell cycle disruption in transformation by Notch(ic). Mol Cell Biol 21, 5925\u20135934 (2001).","journal-title":"Mol Cell Biol"},{"key":"41394_CR24","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1111\/j.1525-1438.2007.00872.x","volume":"17","author":"J Yao","year":"2007","unstructured":"Yao, J., Duan, L., Fan, M., Yuan, J. & Wu, X. Notch1 induces cell cycle arrest and apoptosis in human cervical cancer cells: involvement of nuclear factor kappa B inhibition. Int J Gynecol Cancer 17, 502\u2013510 (2007).","journal-title":"Int J Gynecol Cancer"},{"key":"41394_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-015-0300-x","volume":"14","author":"R Mishra","year":"2015","unstructured":"Mishra, R., Nagini, S. & Rana, A. Expression and inactivation of glycogen synthase kinase 3 alpha\/beta and their association with the expression of cyclin D1 and p53 in oral squamous cell carcinoma progression. Mol Cancer 14, 20 (2015).","journal-title":"Mol Cancer"},{"key":"41394_CR26","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1007\/BF02831393","volume":"25","author":"S Lu","year":"2005","unstructured":"Lu, S., Zhang, B. & Wang, Z. Expression of survivin, cyclinD1, p21(WAF1), caspase-3 in cervical cancer and its relation with prognosis. J Huazhong Univ Sci Technolog Med Sci 25, 78\u201381 (2005).","journal-title":"J Huazhong Univ Sci Technolog Med Sci"},{"key":"41394_CR27","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/1746-1596-8-138","volume":"8","author":"S Liang","year":"2013","unstructured":"Liang, S. et al. CyclinD1, a prominent prognostic marker for endometrial diseases. Diagn Pathol 8, 138 (2013).","journal-title":"Diagn Pathol"},{"key":"41394_CR28","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/jhg.2010.144","volume":"56","author":"C Bonilla","year":"2011","unstructured":"Bonilla, C. et al. Cyclin D1 rare variants in UK multiple adenoma and early-onset colorectal cancer patients. J Hum Genet 56, 58\u201363 (2011).","journal-title":"J Hum Genet"},{"key":"41394_CR29","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1073\/pnas.1011418108","volume":"108","author":"Y Hayakawa","year":"2011","unstructured":"Hayakawa, Y. et al. Apoptosis signal-regulating kinase 1 and cyclin D1 compose a positive feedback loop contributing to tumor growth in gastric cancer. Proc Natl Acad Sci USA 108, 780\u2013785 (2011).","journal-title":"Proc Natl Acad Sci USA"},{"key":"41394_CR30","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1006\/gyno.1999.5346","volume":"73","author":"H Skomedal","year":"1999","unstructured":"Skomedal, H., Kristensen, G. B., Lie, A. K. & Holm, R. Aberrant expression of the cell cycle associated proteins TP53, MDM2, p21, p27, cdk4, cyclin D1, RB, and EGFR in cervical carcinomas. Gynecol Oncol 73, 223\u2013228 (1999).","journal-title":"Gynecol Oncol"},{"key":"41394_CR31","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1006\/gyno.2001.6196","volume":"81","author":"DS Bae","year":"2001","unstructured":"Bae, D. S. et al. Aberrant expression of cyclin D1 is associated with poor prognosis in early stage cervical cancer of the uterus. Gynecol Oncol 81, 341\u2013347 (2001).","journal-title":"Gynecol Oncol"},{"key":"41394_CR32","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.ajog.2003.09.038","volume":"190","author":"JO Schorge","year":"2004","unstructured":"Schorge, J. O. et al. P16 as a molecular biomarker of cervical adenocarcinoma. Am J Obstet Gynecol 190, 668\u2013673 (2004).","journal-title":"Am J Obstet Gynecol"},{"key":"41394_CR33","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1111\/j.1365-2559.2012.04326.x","volume":"61","author":"MH Koay","year":"2012","unstructured":"Koay, M. H., Crook, M. & Stewart, C. J. Cyclin D1, E-cadherin and beta-catenin expression in FIGO Stage IA cervical squamous carcinoma: diagnostic value and evidence for epithelial-mesenchymal transition. Histopathology 61, 1125\u20131133 (2012).","journal-title":"Histopathology"},{"key":"41394_CR34","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1177\/1947601913479022","volume":"3","author":"MC Casimiro","year":"2012","unstructured":"Casimiro, M. C., Crosariol, M., Loro, E., Li, Z. & Pestell, R. G. Cyclins and cell cycle control in cancer and disease. Genes Cancer 3, 649\u2013657 (2012).","journal-title":"Genes Cancer"},{"key":"41394_CR35","doi-asserted-by":"publisher","first-page":"2440","DOI":"10.4161\/cc.5.21.3428","volume":"5","author":"Z Li","year":"2006","unstructured":"Li, Z., Wang, C., Prendergast, G. C. & Pestell, R. G. Cyclin D1 functions in cell migration. Cell Cycle 5, 2440\u20132442 (2006).","journal-title":"Cell Cycle"}],"updated-by":[{"DOI":"10.1038\/s41598-020-63943-3","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2020,4,29]],"date-time":"2020-04-29T00:00:00Z","timestamp":1588118400000}}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-41394-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-41394-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-41394-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T21:40:20Z","timestamp":1721079620000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-41394-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,22]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["41394"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-41394-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,22]]},"assertion":[{"value":"19 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2020","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"An amendment to this paper has been published and can be accessed via a link at the top of the paper.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"5019"}}